PetMed Express (PETS) to Release Quarterly Earnings on Monday
PetMed Express (NASDAQ:PETS) is set to announce its Q213 earnings results on Monday, October 21st. Analysts expect the company to announce earnings of $0.22 per share and revenue of $60.33 million for the quarter.
PetMed Express (NASDAQ:PETS) last announced its earnings results on Monday, July 22nd. The company reported $0.24 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.22 by $0.02. The company had revenue of $74.20 million for the quarter, compared to the consensus estimate of $69.55 million. During the same quarter in the prior year, the company posted $0.20 earnings per share. The company’s quarterly revenue was up 7.5% on a year-over-year basis. On average, analysts expect PetMed Express to post $0.91 EPS for the current fiscal year and $0.96 EPS for the next fiscal year.
PetMed Express (NASDAQ:PETS) traded up 2.77% during mid-day trading on Friday, hitting $16.72. 588,079 shares of the company’s stock traded hands. PetMed Express has a 52 week low of $10.00 and a 52 week high of $17.75. The stock has a 50-day moving average of $16.23 and a 200-day moving average of $14.50. The company has a market cap of $321.8 million and a P/E ratio of 18.08.
Several analysts have recently commented on the stock. Analysts at Zacks reiterated an “outperform” rating on shares of PetMed Express in a research note to investors on Tuesday, September 3rd. They now have a $18.00 price target on the stock. Analysts at Piper Jaffray Cos. raised their price target on shares of PetMed Express from $13.00 to $16.00 in a research note to investors on Tuesday, July 23rd. They now have a “neutral” rating on the stock. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and two have issued a buy rating to the company’s stock. PetMed Express currently has a consensus rating of “Hold” and an average target price of $17.00.
PetMed Express, Inc (NASDAQ:PETS) and its subsidiaries, doing business as 1-800-PetMeds, is a pet pharmacy.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.